Ahmed A.E. Mourad

The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury

Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad et al. · Biomedicine & Pharmacotherapy · 2022 · 81 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Low Dose +22

A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition

Sameh Saber, Eslam E. Abd El-Fattah, Galal Yahya et al. · Pharmaceuticals · 2021 · 70 citations · Full text

Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids

Ahmed A.E. Mourad, Ahmed E. Khodir, Sameh Saber et al. · Pharmaceuticals · 2021 · 54 citations · Full text

Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression

Sameh Saber, Mohamed Nasr, Ahmed S. Saad et al. · Biomedicine & Pharmacotherapy · 2021 · 44 citations · Full text

Albendazole-loaded Cubosomes, Nanotherapeutics, Chemoprevention Strategy +20

Ambroxol, a mucolytic agent, boosts <scp>HO</scp> ‐1, suppresses <scp>NF‐κB</scp> , and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis

Simona Cavalu, Hossam Sharaf, Sameh Saber et al. · The FASEB Journal · 2022 · 44 citations